Viking Therapeutics' Latest Phase 1 Trial Yields Positive Results for Weight-Loss Drug
Wednesday, 27 March 2024, 14:14
Viking Therapeutics' Phase 1 Trial Results
Data from a Phase 1 trial conducted by Viking Therapeutics has revealed positive results for their oral weight-loss drug. The latest findings have analysts supporting buy ratings for the biotech company. This development could pave the way for a new, more accessible option in the weight-loss market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.